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a  b  s  t  r  a  c  t
HIV-1  Nef  is  necessary  and  may  be sufﬁcient  for  HIV-1-associated  AIDS  pathogenicity,  in  that  knock-
out of Nef alone  can  protect  HIV-infected  patients  from  AIDS.  We  therefore  investigated  the feasibility
of  physical  knockout  of Nef,  using  the host  ubiquitin  proteasome  system  in  HIV-1-infected  cells.  Our
co-immunoprecipitation  analysis  demonstrated  that  Nef interacted  with  ubiquitin  speciﬁc  protease  15
(USP15),  and  that  USP15,  which  is known  to stabilize  cellular  proteins,  degraded  Nef.  Nef  could  also
cause  decay  of  USP15,  although  Nef-mediated  degradation  of USP15  was  weaker  than  USP15-mediated
Nef  degradation.  Direct  interaction  between  Nef  and  USP15  was  essential  for  the observed  reciprocal
decay  of  the  proteins.  Further,  USP15  degraded  not  only  Nef but  also  HIV-1 structural  protein,  Gag,
thereby  substantially  inhibiting  HIV-1  replication.  However,  Gag  did not  degrade  USP15,  indicating  that
the  Nef and  USP15  complex,  in  distinction  to  other  viral  proteins,  play  an integral  role  in  coordinating
viral  protein  degradation  and  hence  HIV-1  replication.  Moreover,  Nef  and  USP15  globally  suppressed
ubiquitylation  of  cellular  proteins,  indicating  that  these  proteins  are  major  determinants  for  the stability
of  cellular  as  well  as  viral  proteins.  Taken  together,  these  data  indicate  that  Nef  and  USP15  are  vital  in
regulating  degradation  of viral and  cellular  proteins  and  thus  HIV-1  replication,  and speciﬁc  degradation
of  viral, not  cellular  proteins,  by  USP15  points  to USP15  as  a candidate  therapeutic  agent  to  combat  AIDS
by  eliminating  viral  proteins  from  the infected  cells  via  USP15-mediated  proteosomal  degradation.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Post-translational modiﬁcation of proteins by ubiquitin (Ub)
nd their degradation by the ubiquitin proteasome system (UPS)
as emerged as a major regulatory process in virtually all aspects
f cell biology (Glickman and Ciechanover, 2002). Given the impor-
ance of Ub attachment in regulating the fate and function of
roteins, it is not surprising that HIV-1 takes advantage of the
PS to inﬂuence the interplay between HIV-1 and its host cells
hrough modulating proteostasis of viral and cellular proteins. Pre-
ious studies report that various HIV-1 viral proteins are engaged
n regulation of degradation of cellular counterparts at every step
f the HIV-1 life cycle − from entry into host cells to release of
he infectious progeny viruses to the extracellular milieu to ini-
iate next round of virus life cycle (Cucchiarini et al., 1995; Dang
t al., 2006; Dube et al., 2010; Kutluay et al., 2013; Lindwasser
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/).et al., 2007; Neil et al., 2008; Sakuma et al., 2007). However, it is
completely unknown how these individual events taking place at
different stages of virus life cycle are coordinated and what viral
and cellular molecules dictate these molecular events.
Nef is essential for HIV-1 pathogenesis (Churchill et al., 2004;
Churchill et al., 2006; Kestler et al., 1991; Kirchhoff et al., 1995).
However, molecular details on how the Nef protein determines
HIV-1-mediated AIDS progression are still unclear. One of the key
molecular features of Nef is that, unlike other viral proteins whose
functions are phase- (or stage-) speciﬁc in the virus life cycle, Nef
is the only known viral element which acts throughout the whole
virus life cycle within the host cell: it is translated from the early
viral messages (Cullen, 1991; Ferguson et al., 2002; Haseltine, 1991)
and stays in the infected cells until the protein is packaged into
virion particles (Bukovsky et al., 1997), and thus Nef has temporal
advantages to determine the fate of not only viral but also cellular
proteins throughout the HIV-1 infectious life cycle. Another notable
feature is that subcellular localization of Nef, compared with other
viral proteins which localize to speciﬁc subcellular compartments,
is not conﬁned to the cytoplasmic membrane by myristoylation
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Allan et al., 1985; Franchini et al., 1986), but occurs in diverse
ubcellular organelles, such as endosomes (Dikeakos et al., 2012;
ueck and Neil, 2012; Singh et al., 2009), ER (Park et al., 2014),
itochondria, and even the perinuclear membrane by interacting
ith cellular protein partners (Kammula et al., 2012). Nef is also
nown to play a pivotal role in localization of Env glycoprotein and
ag in late endosomes (Sandrin and Cosset, 2006) and in regulation
f various cellular proteins by inducing endocytosis (Hanna et al.,
998; Sandrin and Cosset, 2006), suggesting that Nef may  have spa-
ial advantages in governing viral and cellular protein fates. These
eports strongly suggest that the described molecular properties
onfer multifarious Nef functions in disease progression.
It is recently reported that Nef degrades Tat protein by the UPS
Sugiyama et al., 2011), which is crucial for an efﬁcient virus replica-
ion, and counteracts the tetherin protein in SIVs, whose genomes
ack vpu (Jia et al., 2009; Sauter et al., 2009; Serra-Moreno et al.,
013; Zhang et al., 2009). Further, it is reported that K144 in HIV-1
ef is di-ubiquitinated for down-regulation of CD4 and MHC-I (Cai
t al., 2011). However, little is known as to whether Nef indeed
lays an essential role in regulating the stability of HIV-1 viral and
ellular proteins and consequent HIV-1 replication and survival of
IV-infected cells, and if so, how and to what degree Nef orches-
rates overall HIV-1 and host cell protein fates during pathogenesis.
o investigate Nef role in protein degradation, we seek to identify
ellular proteins involved in the UPS-mediated protein degrada-
ion through association with Nef and found ubiquitin speciﬁc
rotease 15 (USP15) which stabilizes proteins by deubiquitylation
nd by preventing autoubiquitylation of substrates (Aggarwal and
assague, 2012; Cayli et al., 2009; Inui et al., 2011; Soboleva et al.,
005). Further investigation demonstrated the signiﬁcance of Nef-
nd USP15-mediated viral and cellular protein degradation with
espect to the regulation of the virus life cycle and HIV-1/host cell
ompetition that is essential for AIDS progression.
. Materials and methods
.1. Cells and reagents
Jurkat and 293T cells were cultured in RPMI1640 and Dulbecco
odiﬁed Eagle medium (DMEM), respectively, supplemented
ith 10% heat-inactivated fetal bovine serum (FBS) and 1%
enicillin/streptomycin. Antibodies (Ab) and reagents: Anti-Myc
9E10), −USP15 (2D5), −EEA (H-300), −HA (F-7), and −GFP anti-
odies were purchased from Santa Cruz (Santa Cruz, California)
nd from Clonetech (Takara.Clontech, Mountain View, CA), respec-
ively, anti--actin (O61M4808) antibody was obtained from Sigma
St. Louis, MO), and Alexa Fluor 488 or 555 conjugated to a sec-
ndary antibodies were purchased from Life technologies (Grand
sland, NY). The reagents employed for these experiments are
ycloheximide (Sigma), Baﬁlomycin A1 (Sigma), MG132 (Cayman,
nn Arbor, MI).
.2. Plasmids
USP15-expressing plasmid (pUSP15) was constructed by insert-
ng the open reading frame of USP15 in the pCR-BluntII-topo-USP15
clone ID #40118994, Open Biosystems) between NotI and SalI
estriction sites of pCMV-Myc (Company). N- and C-terminal dele-
ion mutants of USP15, pUSP15N and pUSP15C, respectively,
ere generated, using restriction endonucleases. Similarly, the
oding regions of nef of HXBc2 and YU2 strains of HIV-1 were cloned
nto EcoRI and BamHI sites of pCDNA3.1(−)-Myc.His (Agilent, Santa
lara, CA) to generate pHNef and pYNef, respectively. pHN.GFP
lasmid encoding Nef.GFP fusion protein was constructed by plac-
ng nef-coding region in pHNef into pEGFP-N3 (Takara.Clontech,h 223 (2016) 161–169
Mountain View, CA), using EcoRI and BamHI restriction endonu-
cleases. pDsRed2-ER was  purchased from Clontech (Mountain
View, CA), and the ubiquitin (Ub)-expressing plasmid, pUb-HA and
Gag-expressing plasmid, psPax2 are described in detail elsewhere
(Timani et al., 2014) and (Zufferey et al., 1997), respectively.
2.3. Western blot (WB) and immunoprecipitation analysis
Cells were washed twice in ice-cold PBS, suspended in the lysis
buffer containing 50 mM Tris-HCl pH 7.4, 300 mM NaCl, 1% NP-40,
50 mM NaF, 1 mM NaVO4, 1 mM PMSF and 1x protease inhibitor
cocktail (Calbiochem, La Jolla, CA), and incubated on ice for 20 min.
After centrifugation at 20,000g at 4 ◦C for 20 min, the supernatants
were collected and saved as cell lysates. The lysates were then
employed for immunoprecipitation and Western blot analysis, as
described (Park et al., 2013).
2.4. Confocal microscopic analysis
Cells grown on polylysine-coated cover slips were transfected
with the indicated plasmids and cultured for 48 h. Cells were then
washed twice with PBS, ﬁxed in 4% paraformaldehyde, permeabi-
lized with 0.3% Triton X-100 for 5 min, and blocked in 2.5% BSA for
30 min. Cells were incubated with the primary antibody followed
by Alexa Fluor 488 or 555 conjugated to secondary antibodies at
room temperature for 1 h each and washed three times with PBS to
visualize subcellular localization of the indicated proteins with an
confocal microscope, as described (Park et al., 2014).
2.5. Cycloheximide determination of protein half-life
To investigate whether the observed reductions in the amount
of USP15 and Nef were due to the degradation of the expressed
proteins, 293T cells transfected with pUSP15 and/or pHNef were
treated with 40 g/ml of cycloheximide (CHX) (Sigma Aldrich, St.
Louis, MO)  at 48 h post-transfection for the indicated time periods,
and changes to protein levels were determined by WB analyses, as
described above.
2.6. Reverse transcriptase (RT) assay and preparation of virions
For RT assay, virions in the supernatant were pelleted by cen-
trifugation at 12,000g for 1 h, and the RT activity was determined,
as described (Pyeon and Park, 2015). For virion preparation for WB,
cells and cell debris in the culture supernatant were removed by
centrifugation at 800g for 100 min, and the cleared supernatant
was passed through a 0.22 m ﬁlter (Corning, NY) to ensure com-
plete removal of smaller cell debris. Virions in the ﬁltrate were
precipitated in 20% sucrose in PBS by centrifugation at 238,000g
for 90 min, as described (Pyeon and Park, 2015), and virion proteins
were analyzed by WB,  as described above.
2.7. Data analysis
All values are expressed as means +/−SD of triplicate experi-
ments. All comparisons were by a controlled two-tailed Student’s
t-test. A p value of <0.05 was  considered statistically signiﬁcant (*),
and p < 0.01 highly signiﬁcant (**).
3. Results
3.1. Signiﬁcant amounts of the viral proteins remained in the
infected cells without being packaged into virions
Our WB  analysis using anti-p24 antibody showed that only a
fraction of Gag protein was  assembled into virion particles, while
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Fig. 1. Replication of HIV-1 in Jurkat and WB analysis of viral proteins. (A) HIV-1 corresponding to 10,000 cpm/ml was  infected into Jurkat cells (1 × 106 cells), and replication
kinetics of HIV-1 was determined by measuring RT activity in the culture supernatants every 3 days. (B) HIV-1 was infected into Jurkat cells, and cell (left) and virus (right)
lysates  were prepared at peak virus replication. 1/5 and 1/2 of total lysates of cells and virus (supernatants), respectively, were employed for the analysis. Band intensity of
p24  (arrow) in the supernatant was approximately 1/3 of that in the cells.
Fig. 2. Reciprocal regulation of USP15 and Nef stability. (A) Association between Nef and USP15. 293T cells were transfected with pUSP15 (lane 1) or with pHNef and pUSP15
(lane  2), and proteins from the transfected cells were precipitated with anti-USP15 Ab followed by WB  with anti-USP15 ﬁrst and the same blot with anti-Myc Ab again which
can  detect both Nef and USP15 tagged with Myc  (lane 2), indicating that Nef was  co-precipitated with USP15. HC and LC represent immunoglobulin heavy and light chain,
respectively. (B) Changes of the amount of endogenous USP15 by Nef. 293T cells were transfected with increasing amounts of nef-expressing plasmid (0, 1, 2, and 4 g from
left  to right), and changes of the amount of endogenous USP15 was  determined by WB  analysis, using anti-USP15 antibody. Protein loading in each lane was determined to be
equal  by reprobing the membrane with anti-actin antibody (lower panel). The total transfected DNA was adjusted for equivalence by adding control plasmid pC3 (pCDNA3)
in  each transfection hereafter to eliminate discrepancies which might be arisen by the promoter competition. (C) Nef-mediated degradation of USP15. USP15-expressing
plasmid alone (lane 1) or together with nef-expressing plasmids of the HXBc2 (lane 2) and the YU2 (lane 3) was  transfected into 293T cells, and Western blot analysis was
performed with the transfected cell lysates. (D) USP15-mediated degradation of Nef. Increasing concentration of USP15 (0, 1, 2, and 4 g from lanes 2–5, respectively) reduced
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(he  amount of Nef in 293T cells. The data were representative of three independentigniﬁcant amount of the viral proteins remained in the infected
urkat cells (Fig. 1B), even when the amount of HIV-1 virion in
he culture supernatants reached to the peak (9 day post-infection)
Fig. 1A). Why, then, does HIV-1 infection yield such large amountsriments.of viral protein, even if only a small fraction of the protein produced
is employed in generating infectious progeny, and what is the role
and fate of the intracellular viral proteins remaining in the infected
cells? We  hypothesized that this high percentage of the intracel-
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Fig. 3. Effect of CHX. USP15- and/or Nef-expressing plasmids were transfected into
293T cells, and at forty-eight hours pos-transfection, the transfected cells were
treated with CHX for the indicated time. Changes in the amount of USP15 and Nef
were then determined in the cells transfected with USP15- (left), Nef- (middle),
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ir  USP15- and Nef-expressing plasmids (right) by WB  analysis (above) followed by
uantiﬁcation based on the amount of -actin. The data were representative of three
ndependent experiments.
ular viral proteins, speciﬁcally Nef, within the cells is required for
ompeting with the infected host in regulating stabilities of cellular
estriction factors.
Since Nef is clearly vital to HIV-1 pathobiology in the clinic, but
omprehensive in vitro modeling of the gene has been restricted by
ts dispensibility to continuous virus replication in the susceptible
ells (Joseph et al., 2005; Neri et al., 2011; Schindler et al., 2007),
e adopted an alternative strategy that opens with single-cycle
nalysis of molecular events occurring within 293T cells to answer
he above questions.
.2. HIV-1 Nef and USP15 interacted and reciprocally regulated
heir stability
To investigate the involvement of Nef in degradation of viral
nd cellular proteins, we performed the yeast two-hybrid analysis
o screen for cellular proteins associating with Nef, as described
Kalpana et al., 1994), and identiﬁed USP15. To conﬁrm associa-
ion of USP15 with Nef, 293T cells were transfected with pUSP15
lane 1) or with pHNef and pUSP15 (lane 2), and proteins from the
ransfected cells were precipitated with anti-USP15 Ab followed
y WB with anti-USP15 ﬁrst and the same blot with anti-Myc Ab
gain. Therefore, lane 1 should detect only USP15, while lane 2 in
ig. 2A could detect both USP15 and Nef. Our data showed that
ef was detected in lane 2 together with USP15, but not in lane 1
Fig. 2A), indicating that Nef associated with USP15 and suggesting
hat Nef could be important to UPS-mediated proteosomal degra-
ation processes. We  next examined the effect of Nef expression on
ntracellular USP15 levels by WB analysis of transfecting increas-h 223 (2016) 161–169
ing concentration of pHNef into 293T cells. Our data showed that
as the amount of pHNef was increased from 0 to 4 g, the USP15
levels gradually decreased in a dose-dependent manner (Fig. 2B)
without changes to the amount of -actin (Fig. 2B), indicating that
Nef expression caused the intracellular USP15 diminution. Paral-
leling the pHNef expression (lane 2, Fig. 2C), transfection of pYNef
expressing R-tropic nef (YU2 strain) of HIV-1 reduced the amount
of USP15 (lane 3, Fig. 2C), establishing that the observed decreases
of USP15 were not just strain speciﬁc but were common to differ-
ent strains of HIV-1 Nef. We  then examined the effect of USP15
expression on the Nef levels. As shown in Fig. 2D, the amount of
Nef gradually declined, as the amount of pUSP15 transfected into
293T was  increased from 0 to 4 g, demonstrating that USP15 can
also decrease the amount of the expressed intracellular Nef. These
ﬁndings indicated that the amounts of intracellular Nef and USP15
were mutually regulated.
3.3. Reduction of USP15 and Nef was due to the reciprocal
degradation of the expressed protein
Next, we investigated whether the observed reduction was due
to the reciprocal degradation of the expressed USP15 and Nef. To
this end, 293T cells transfected with pUSP15 (4 g) and pHNef
(2 g) were treated with cycloheximide (CHX) for the indicated
time period at 48 h post-transfection, and changes in the amounts
of Nef and USP15 were determined by WB (Fig. 3, above) with
Bio-Rad image quantitation based on -actin changes (Fig. 3 line
graph). The results showed that the amount of the intracellular
USP15 slightly increased in the absence of Nef, while the expressed
USP15 levels was  reduced in the presence of Nef, indicating that
USP15 diminution in the presence of Nef was due to the degra-
dation of the expressed USP15 (Fig. 3). Under the same condition,
the amount of Nef protein also increased in the absence of USP15
(Fig. 3A and B), while Nef levels signiﬁcantly declined when the
cells were co-transfected with pUSP15 − and the reduction was
more dramatic in Nef than in USP15 (Fig. 3) − establishing that the
lowered intensity of the protein bands was due to the degradation
of the expressed proteins. Taken together, the results show that
Nef and USP15 declines were due to expressed protein degrada-
tion, and USP15-mediated degradation of Nef was much stronger
than Nef-mediated USP15 degradation (Fig. 3).
3.4. Association of Nef with USP15 is critical for the reciprocal
regulation of decays of the proteins
We  next investigated whether direct interactions between Nef
and USP15 are essential for the observed reciprocal decay of the
proteins. Accordingly, we  constructed two  deletion mutants of
USP15, USP15N  and USP15C  (Fig. 4A), and examined binding
of Nef to the mutant USP15 and its consequence to the recipro-
cal decay of mutant USP15 and Nef. WB analysis showed that GFP
and Nef.GFP fusion protein were expressed efﬁciently (Fig. 4B, top
panel), and USP15 and its mutant proteins were also expressed
with the expected molecular weights, even if the expression level
of USP15N  was  relatively poor (Fig. 4B, middle panel). Immu-
noprecipitation of USP15 and its mutant proteins with anti-Myc
antibody, followed by WB with anti-GFP antibody for the detection
of Nef.GFP and GFP, showed that Nef.GFP, not GFP, was  detected
only in the cells transfected with wild type- or USPN-, but not
with USPC-expressing plasmids (Fig. 4B bottom panel), indicat-
ing that Nef binds USP15 through the encoded protein motif(s) from
amino acid 385 to the end of the USP15 gene. We  then investigated
whether the interaction between USP15 and Nef is required for the
observed mutual degradation. Fig. 3C showed that the amounts of
the expressed USP15 and USP15N  which interact with Nef gradu-
ally declined as the amount of Nef was increased. However, we  did
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Fig. 4. Association and degradation of USP15 and Nef. (A) Schematic representation of USP15 and its mutants. Arabic numbers indicate amino acid number of USP15,
and  dashed lines in USP15N  and USP15C  denote deletions. DUSP, UBL, and UCH in the gray boxes are abbreviations of domain present in ubiquitin-speciﬁc protease,
ubiquitin-like fold, and ubiquitin carboxyl-terminal hydrolase, respectively. (B) Binding of Nef with USP15. pUSP15 or its mutant plasmids (pUSP15N and pUSP15C)
was  co-transfected with either pHN.GFP or pEGFP-N3 into 293T cells, and association of Nef with the wild type- or mutant USP15 was investigated by IP followed by WB.
Expression of Nef.GFP or GFP (top panel) was determined by WB  with rabbit anti-GFP antibody, and that of USP15 and its mutant proteins (middle panel) was detected with
mouse  anti-Myc antibody, wherein low exposed USP15 band was  cut and pasted to the same image (*). The lower panel shows association of Nef with USP15, by IP with
anti-Myc antibody for USP15 and its mutant proteins, followed by WB with anti-GFP antibody. Arabic numbers on the left of each image indicate positions of pre-stained
protein size marker (kDa) (Fisher Scientiﬁc, Pittsburgh, PA). (C) Degradation of USP15 and its mutant proteins by Nef. Increasing concentrations of Nef (0, 1, 2, and 4 g from
lanes  1–4, respectively, in each bracket) were co-transfected with 2 g of pUSP15, pUSP15N, or pUSP15C into 293T cells, and changes in the amount of each protein
were  analyzed by WB analysis. Protein loading in each lane was determined to be equal by reprobing the membrane with anti-actin antibody (lower panel). The data were
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ot observe any appreciable reduction in USP15C,  which failed
o interact with Nef (Fig. 4C), evincing that Nef-triggered decay of
SP15 requires the deleted segment. Similarly, the amount of Nef
as least in the cells transfected with pUSP15, as well as less in the
ells transfected with pUSP15N than in the cells transfected with
USP15C (Fig. 4C), establishing that interaction of USP15 and Nef
s essential for the reciprocal protein decay.
.5. Both USP15 and Nef were ubiquitylated
Since Ub attachment to proteins followed by degradation of the
roteins by UPS plays an integral role in regulation of the fate of pro-
eins, we investigated the possibility of ubiquitylation of Nef and
SP15. To this end, pUb-HA together with pHNef or pUSP15 were
ransfected into 293T cells, and expression and ubiquitylation of
ef and USP15 were determined by WB  analysis (lane 1, Fig. 5A)
nd by immunoprecipitation with anti-HA antibody followed by
B analysis with anti-Myc antibody for the detection of Nef and
SP15 (lane 2, Fig. 5A), respectively. Our data showed that both Nef
nd USP15 were expressed with the expected sizes of molecules,
nd the expressed proteins were ubiquitylated, indicating that the
bserved decay of the proteins was achieved by the UPS. Next, we
tudied whether expression of USP15 and Nef affects ubiquityla-
ion of cellular protein in general. Accordingly, pHNef and pUSP15
ere transfected into 293T cells, and effects of Nef or USP15 on
biquinitylation of cellular proteins were determined by WB anal-
sis with anti-HA Ab. As shown in Fig. 5B and C, the amount of theubiquitylated cellular proteins was  signiﬁcantly diminished with
increasing concentration of pUSP15 or pHNef plasmid, showing
that both Nef and USP15 play an important role in governing cel-
lular protein stability. In light of the innate function of USP15 to
block protein ubiquitylation, the inhibition by USP15 with respect
to ubiquitylation, as shown in Fig. 5, was expected. However, it is
remarkable that Nef degraded USP15 but reduced ubiquitylation to
thereby stabilize cellular proteins in general. These data collectively
demonstrate that USP15 and Nef could be degraded by the UPS  and
that these two  proteins are involved in regulating degradation of
both viral and cellular proteins.
3.6. Nef and USP15 co-localized to the same subcellular
compartments
Nef is known to reside at the cytoplasmic membrane (Fackler
et al., 1997; Kaminchik et al., 1994; Kammula et al., 2012; Yu and
Felsted, 1992), while subcellular localization of USP15 is poorly
understood. Since our data indicated that the stability of Nef and
USP15 was  affected bilaterally, we examined the possibility that
Nef and USP15 co-localize to the same subcellular compartments
of 293T cells transfected with pNef.GFP and pUSP15, using confocal
microscopic analysis. Our data showed that a signiﬁcant portion of
Nef co-localized with USP15 in the cytosolic compartment (Fig. 6A).
Expression of USP15 was  also detected in the ER (Fig. 6B) where
Nef protein was detected (Park et al., 2014). Further, USP15 was
located in the early endosome (Fig. 6C) where endosomal protein
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Fig. 5. Ubiquitylation of viral and cellular proteins. (A) Ubiquitylation of USP15 and
Nef. Ub-expressing plasmid (pUb) was transfected with USP15- (Top) or with nef-
expressing plasmid (Bottom), and ubiquitylation of these proteins was  determined
by  immunoprecipitation with anti-HA Ab for Ub followed by Western blot analy-
sis  with anti-USP15 (Top) or anti-Myc antibody for Nef (lane 2). Lane 1 indicates
WB  analysis of USP15 (Top) and Nef (Bottom). Arabic numbers on the left indi-
cate positions of pre-stained protein size marker (kDa) (Fisher Scientiﬁc). (B and
C)  Ubiquitylation of cellular proteins. Total cell lysates generated from 293T cells
transfected with pUb and 1 or 4 g of USP15- or Nef-expressors were analyzed by
WB  with anti-HA Ab for ubiquitylated cellular proteins, followed with anti-Myc
Ab  for USP15 and Nef, and anti--actin Ab for -actin protein, and (C) the rela-
tive  amount of ubiquitylated proteins was determined by scanning the entire area
of each lane, using ChemiDoc Touch Imaging System (Bio-Rad, Hercules, CA) and66 D. Pyeon et al. / Virus R
egradation takes place, and Nef was also observed in the endo-
omes together with the early endosomal antigen (EEA) (Fig. 6D),
uggesting that USP15 and Nef could regulate their own  and other
roteins’ destiny cooperatively in the same subcellular organelles.
nterestingly, USP15 is known to contain a putative nucleolus local-
zation signal (Soboleva et al., 2005). However, we did not detect
igniﬁcant amounts of USP15 in the nucleus.
.7. USP15 also degraded viral structural protein and thus
mpaired HIV-1 replication
The above data demonstrated that Nef and USP15 degraded
eciprocally and that USP15-mediated degradation of Nef was  very
ronounced, compared with Nef-mediated decay of USP15. We
hus investigated whether USP15 impairs stability of other viral
roteins, such as Gag, and thus alters HIV-1 replication. Accord-
ngly, we transfected 293T cells with different amounts of wt-  and
nef-HIV-1 proviral DNA, and changes in the amount of intracel-
ular viral proteins, Gag, and in virus replication in the presence
f USP15 were monitored by WB  analysis and RT assay, respec-
ively. Our WB  analyses showed that transfection of increasing
SP15-expressing plasmid levels reduced the amount of p24 in a
ose-dependent fashion in both wt- and nef-HIV-1 (Fig. 7A and
, respectively), and decreases of p24 were more noticeable with
nef-HIV-1, as depicted in Fig. 7C. In parallel, replication of wt-  and
nef-HIV-1 (Fig. 7, below A and B, respectively) was  signiﬁcantly
mpaired by USP15, indicating that USP15 degraded not only Nef
ut also Gag and thus hampered HIV-1 replication. Our ensuing
tudy indicated that these changes in the amount of viral proteins
ere due to the intracellular degradation, not to the inhibition of
iral gene expression (data not shown).
.8. Both endosomal and proteosomal degradation pathways
ere critical for USP15-triggered degradation of viral proteins
We  next investigated how USP15 degraded Gag. In light of
he previous reports that Nef drives Gag to endosomes (Sandrin
nd Cosset, 2006) and that USP15 is essentially ubiquitous in the
ytosolic compartments, as shown above (Fig. 6), it is reasonable
o hypothesize that USP15 could degrade the structural protein
ia both enodosomal and proteosomal degradation pathways. To
est this possibility, we investigated the effects of endosomal and
roteosomal degradation inhibitors, using MG132 (Fig. 8B) and
aﬁlomycin A1 (Fig. 8C), respectively, on degradation of Gag. Our
ata showed that in the absence of MG132 (Fig. 8A), p24 was
egraded, as the amount of USP15 was increased. However, the
bserved degradation of p24 by USP15 was effectively abrogated,
hen the transfected cells were treated with MG132 (Fig. 8B), indi-
ating that the proteosomal degradation pathway plays a key role in
SP15- mediated degradation of Gag protein. Remarkably, the band
ntensity of p24 by USP15 was visibly weaker, when the cells were
reated with Baﬁlomycin A1 (compare p24 intensity in Fig. 8C with
), indicating that endosomal degradation inhibitor actually accel-
rated p24 degradation by unknown mechanism. Taken together
hese data showed that USP15-mediated degradation of Gag was
odulated via both endosomal and proteosomal degradation cas-
ades.
. Discussion
Our data demonstrated that cellular protein, USP15, regulates
egradation of the intracellular viral proteins in HIV-1 replicating
ells using the UPS, and that HIV-1 Nef interacts with and deter-
ines the fate of USP15, suggesting that Nef and USP15 play a
ivotal role for inter-regulation of HIV-1/host cell competition indepicted as mean +/−SD of triplicates, shown in (B). The data were representative
of  three independent experiments.
the infected cells, which may  be integral to AIDS progression. Fur-
ther, while the amount of intracellular Nef and USP15 was mutually
regulated, USP15-mediated degradation of Nef was  stronger than
Nef-mediated USP15 degradation, implying that USP15 could be
employed to knock out Nef, a molecule essential to pathogenicity,
within HIV-1 infected cells.
Our WB  analysis using anti-p24 antibody showed that signiﬁ-
cantly more viral proteins remained in the infected Jurkat cells than
in the virion particles at peak virus replication (Fig. 1). These data
suggest that this large percentage of intracellular viral proteins in
the host is critical for competition between the infecting HIV-1 and
the infected host cells. Accordingly, USP15 degraded key intracel-
lular viral proteins, such as Nef and Gag in the HIV-1-replicating
cells and thereby signiﬁcantly impaired HIV-1 replication, and Nef
induced decay of USP15 which is known to stabilize cellular pro-
teins (Aggarwal and Massague, 2012; Cayli et al., 2009; Inui et al.,
2011; Soboleva et al., 2005). These data evinced that Nef and USP15
are key players in governing intracellular viral and cellular protein
stability and thus the HIV-1/host cell competition, determining the
course of disease.
Our data indicated that USP15 clearly induced degradation of
Nef and other viral structural protein, Gag, in the repeated exper-
iments. How, then, can USP15 speciﬁcally target viral proteins
for decay, while stabilizing cellular proteins in the HIV-1-infected
cells? One conceivable mechanism is that USP15 comprises two
distinct functional domains, wherein one domain is critical for
blocking degradation of cellular proteins, while another motif
is important for degradation of foreign pathogenic molecules to
restrict replication of the invading pathogen, e.g. HIV-1. This pos-
sibility can be tested by introducing mutations in the USP15 gene
and by assessing the effect of the mutations on speciﬁc viral protein
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Fig. 6. Confocal microscopy. Subcellular localization was determined by confocal microscopic analysis after transfecting USP15- and/or nef.GFP-expressing plasmids into
293T  cells. USP15 was  detected by anti-USP15 Ab followed by Alexa Fluor 488 (Fig. 6B) or Alexa Fluor 555 (Fig. 6A and C), Nef showed as green by fusion of the protein with
G  Ab fo
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tFP  (Fig. 6A and D), and early endosomal antigen (EEA) was identiﬁed by anti-EEA
DsRed2-ER encodes a fusion consisting of red ﬂuorescence protein, showing red co
f  the references to colour in this ﬁgure legend, the reader is referred to the web ve
egradation. Alternatively, USP15 could activate other cellular pro-
ein(s) in the USP15/Nef complex, and the activated protein(s) in
urn degrades Nef protein. We  accordingly screened for a poten-
ial cellular component involved in the UPS-mediated protein
egradation by interacting with Nef, using the yeast- followed by
he mammalian-two-hybrid assays (Kalpana et al., 1994; Pyeon
nd Park, 2015). We  found that Nef binds to ubiquitin-protein
igase E3A (UBE3A/E6AP) which induces protein degradation by
ttaching Ub to substrates (Bernassola et al., 2008; Vande Pol and
lingelhutz, 2013), i.e. Nef associated with two functionally antago-
istic proteins in the UPS-mediated protein degradation processes,
uggesting that UBE3A could be a major cellular component in reg-
lating USP15-mediated viral protein degradation by interacting
ith Nef and USP15 simultaneously or independently. These pos-
ibilities remain to be studied.
USP15 degraded not only Nef but also Gag, and the USP15-
ediated inhibitory effect on wt-HIV-1 replication was  more
ronounced than on nef-HIV-1 replication (Fig. 7). These data
ndicate that Nef expressed from the wt-HIV-1-, but not from nef-
IV-1-replicating cells, degraded USP15, lowering the amount of
ntracellular USP15, which in turn vitiated USP15-induced degra-
ation of viral proteins and thereby HIV-1 replication, where Nef
egrades USP15, but USP15-mediated Nef degradation is more
otent (Fig. 3). The observed changes in the amount of viral pro-
eins were not due to the inhibition of viral gene expression but tollowed by Alexa Fluor 488 (Fig. 6C) and by Alexa Fluor 555 (Fig. 6D). Expression of
the endoplasmic reticulum (ER) of the transfected cells (Fig. 6B). (For interpretation
of this article.)
the intracellular degradation, since luciferase activity of HIV-1 LTR
FLuc was  not diminished by expression of USP15 (data not shown).
Our observations raise the question of how USP15 would medi-
ate degradation of Gag. From earlier ﬁndings that Nef directs Gag
to endosomes (Sandrin and Cosset, 2006), and USP15 and Nef are
largely omnipresent in the cytosolic compartments (Fig. 6), one
may  postulate that USP15 alone or together with Nef degrades the
structural protein via both the enodosomal and proteosomal degra-
dation routes. It would be interesting to investigate on whether
and how Nef regulates USP15-triggerred degradation of Gag. In
corroboration, the observed degradation of p24 by USP15 (Fig. 8A)
was thoroughly abrogated, when the transfected cells were treated
with MG132 (Fig. 8B), indicating that the proteosomal degradation
pathway acts on the USP15-mediated degradation of Gag pro-
tein. Remarkably, the band intensity of p24 degraded by USP15
was visibly weaker (Fig. 8C vs A), when the cells were treated
with Baﬁlomycin A1. These data establish that USP15-mediated
p24 degradation is achieved via both endosomal and proteosomal
degradation.
These data collectively demonstrated that stability of Nef and
USP15 is regulated reciprocally, and that USP15-mediated degrada-
tion of Nef was  more pronounced than Nef-mediated degradation
of USP15. Further, Nef, but not Gag, degraded USP15, suggesting
that reciprocal degradation of Nef and USP15 could play a central
role in coordinating decay of viral proteins and hence HIV-1 replica-
168 D. Pyeon et al. / Virus Research 223 (2016) 161–169
Fig. 7. Effect of USP15 on degradation of Gag and HIV-1 replication. (A) and (B) Western blot analysis from cells transfected with wt- and nef-HIV-1. Lane 1 indicates
293T  cells transfected with isotype plasmids, while lanes 2–5 in (A) and (B) represent 293T cells transfected with 4 g of wt- (A) or nef-HIV-proviral DNA together with
0,  1, 2, and 4 g of USP15-expressing plasmid, respectively. Bar graphs below (A) and (B) represent replication activity of wt- and nef-HIV-1 in 293T cells measured by RT
activity in the presence of different doses of USP15. (C) depicts relative amount of p24 in panel (A) and (B) normalized based on -actin. The data were representative of
three  independent experiments.
Fig. 8. Effect of proteosomal (B) or endosomal (C) protein degradation inhibitor on USP15- (open triangle) mediated degradation of Gag. 293T cells were transfected with
4  g HIV-1 proviral DNA together with 1, 2, and 4 g of USP15-expressing plasmid, and at 48 h post-transfection, cells were treated with DMSO (A) or with either 2 M
MG132  (B) or 100 nM Baﬁlomycin A1 (C) for 6 h. WB  analysis was  then performed with each cell lysate with anti-p24 Ab for p24, and the data were representative of three
independent experiments. (D) The amount of p24 in the cells treated with DMSO, MG132, or Baﬁlomycin A1 (Baf.) of three independent experiments was determined by
s d, Her
t
d
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Ccanning  the corresponding bands, using ChemiDoc Touch Imaging System (Bio-Ra
ion, underlining the dynamic competition between the molecular
eterminants of the infecting HIV-1 and the infected host cells.
oing forward, to maximize biomedical relevance, these experi-
ents should also be conducted in HIV-1-susceptible primary and
stablished CD + 4T cells, though there could be drawbacks as well
s advantages to multifarious host-dependent Nef behaviors that
ay  arise in different cell lines. Additionally, our results suggest
he need to examine whether blockage of endogenous expression
f USP15 reverses USP15-mediated degradation of viral proteins
nd thus the impairment of HIV-1 replication. We  believe that by
lucidating the detailed structural basis for Nef/USP15-corrdinated
rotein degradation, we can improve our understanding of the
ompeting viral pathogenicity and cellular defense strategies set-
ing the course of disease, and we can retrieve key molecular targets
or enhancing therapeutics against AIDS.onﬂict of interest
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